Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:07 PM
Ignite Modification Date:
2025-12-24 @ 9:07 PM
NCT ID:
NCT04446104
Eligibility Criteria:
Inclusion Criteria:
Subjects must meet all the of following criteria to be included in this study:
* Men residing in dormitory aged 21-60 years
* Willing and able to give informed consent
* Able to understand instructions and consume study medications according to the study protocol.
* Weight more than 40kg
* Owns a mobile phone (with wireless fidelity and/or 3G connection and able to fill in online forms.
Exclusion Criteria:
Subjects who have any of the following criteria at baseline will be excluded from participating in this study:
* Symptoms of acute respiratory illness (e.g. fever, runny nose, sore throat, cough, breathlessness, loss of smell and loss of taste) for the past 30 days
* Known current or history of SARS-CoV-2 infection
* Unable to read English or any of the available local languages used for this clinical trial
* History of cardiac or neurological diseases
* History of retinal diseases
* History of diabetes on insulin treatment
* History of depression
* History of chronic alcohol use
* History of renal or hepatic dysfunction
* History of glucose-6-phosphate dehydrogenase deficiency
* History of anaemia, after exposure to any given medications
* History of thyroid disorder, hyperthyroidism, or sensitivity to iodine
* History of allergies with systemic presentation to any given medication (e.g.: swelling of the face, throat, eyes and lips, respiratory disturbances, asthmatic attacks, widespread skin blistering or urticaria (hives))
* Concomitant medication that may lead to cardiac arrhythmia (azithromycin, amitriptyline, cimetidine, citalopram, nortriptyline, pantoprazole, quetiapine etc).
* Unwilling to comply with study dosing, instructions or restrictions.
Healthy Volunteers:
True
Sex:
MALE
Minimum Age:
21 Years
Maximum Age:
60 Years
Study:
NCT04446104
Study Brief:
Protocol Section:
NCT04446104